Vivani Medical Inc
NASDAQ:VANI

Watchlist Manager
Vivani Medical Inc Logo
Vivani Medical Inc
NASDAQ:VANI
Watchlist
Price: 1.4305 USD -0.66%
Market Cap: 79m USD
Have any thoughts about
Vivani Medical Inc?
Write Note

Vivani Medical Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vivani Medical Inc
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Vivani Medical Inc
NASDAQ:VANI
Other Liabilities
$18.6m
CAGR 3-Years
399%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Other Liabilities
$942m
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
Boston Scientific Corp
NYSE:BSX
Other Liabilities
$1.8B
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
Stryker Corp
NYSE:SYK
Other Liabilities
$2.7B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Other Liabilities
$6.6B
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
3%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Liabilities
$389.1m
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
16%
No Stocks Found

Vivani Medical Inc
Glance View

Market Cap
79m USD
Industry
Health Care

Vivani Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Emeryville, California and currently employs 15 full-time employees. The company went IPO on 2014-11-19. Vivani Medical, Inc., formerly Second Sight Medical Products, Inc., is a developer of implantable visual prosthetics that creates an artificial form of useful vision for blind individuals. The firm is the combination of Nano Precision Medical, Inc. (NPM) and Second Sight Medical Products, Inc. NPM is a biopharmaceutical business that develops miniaturized, subdermal drug implants utilizing its NanoPortal technology to enable long-term, near constant-rate delivery of medicines to treat chronic diseases. Its divisions include Drug Implant & Visual Protheses division. The firm's Drug Implant division is developing a portfolio of miniature drug implants which utilize its NanoPortal drug implant technology. Its lead product, NPM-119, is a GLP-1 receptor agonist under development to treat patients with type two diabetes. The firm's Visual Protheses division is developing implantable visual prostheses devices that are intended to deliver useful artificial vision to blind individuals.

VANI Intrinsic Value
0.4516 USD
Overvaluation 68%
Intrinsic Value
Price

See Also

What is Vivani Medical Inc's Other Liabilities?
Other Liabilities
18.6m USD

Based on the financial report for Jun 30, 2024, Vivani Medical Inc's Other Liabilities amounts to 18.6m USD.

What is Vivani Medical Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
50%

Over the last year, the Other Liabilities growth was -8%. The average annual Other Liabilities growth rates for Vivani Medical Inc have been 399% over the past three years , 50% over the past five years .

Back to Top